Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Nektar Therapeutics - Common Stock (NQ:NKTR)

51.41 +1.52 (+3.05%)
Streaming Delayed Price Updated: 10:18 AM EDT, Sep 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 292,470
Open 50.32
Bid (Size) 51.33 (2)
Ask (Size) 51.49 (3)
Prev. Close 49.89
Today's Range 50.08 - 51.76
52wk Range 6.480 - 50.53
Shares Outstanding 183,801,441
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Nektar Therapeutics Rippled Higher This Week
The company's competitive positioning might be stronger now, after disappointing results from a key rival. 
Via The Motley Fool
Topics Intellectual Property
What's Going On With Nektar Therapeutics Stock On Thursday?
Nektar Therapeutics stock is trading higher with no news, possibly due to Sanofi's disappointing results. 
Via Benzinga

Performance

YTD
+256.6%
+256.6%
1 Month
+87.4%
+87.4%
3 Month
+488.9%
+488.9%
6 Month
+289.4%
+289.4%
1 Year
+169.9%
+169.9%

More News

Read More
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Shoe Carnival, American Eagle, Ciena, Victoria's Secret And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Earnings Scheduled For August 7, 2025
Via Benzinga
Why Nektar Therapeutics Stock Popped 6% on Friday
Via The Motley Fool
Nektar (NKTR) Q2 Revenue Falls 52%
Via The Motley Fool
3 Bullish Biotech Stocks With Explosive Growth Trends
Via MarketBeat
Why Nektar Therapeutics Stock Dived by 3% Today
Via The Motley Fool
US Stock Futures Slip After Two Days Of Record Advances: 'FOMO Could Add Another 5%-10%...,' Says Expert
Via Benzinga
MSC Industrial Direct, Constellation Brands And 3 Stocks To Watch Heading Into Tuesday
Via Benzinga
Biotech Catalyst Alert: NKTR, CDTX & WGS Rallying With Big Gains
Via MarketBeat
Nektar Jumps 157% on Drug Trial Data—Can It Go Even Higher?
Via MarketBeat
Nektar Nails Phase 2b Eczema Trial: BTIG Calls It A ‘Pound the Table BUY’, Wainwright Sees $120 Upside
Via Stocktwits
Why Nektar Therapeutics Stock Was Red-Hot Today
Via The Motley Fool
Why Is Nektar Therapeutics Stock Trading Higher On Wednesday?
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
AeroVironment Posts Better-Than-Expected Earnings, Joins QuantumScape, Bumble, BlackBerry And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Let's have a look at the top gainers and losers in the middle of the day of today's session.
Via Chartmill
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Nektar Therapeutics Announces Positive Data From Eczema Drug In Mid-stage Trial: Stock More Than Doubles But Retail Sees It Rising Further
Via Stocktwits
Topics Economy Government
Crude Oil Falls Sharply; US Current Account Deficit Widens In Q1
Via Benzinga
Let's have a look at the top gainers and losers in the middle of the day of today's session.
Via Chartmill
Which stocks are gapping on Tuesday?
Via Chartmill

Frequently Asked Questions

Is Nektar Therapeutics - Common Stock publicly traded?
Yes, Nektar Therapeutics - Common Stock is publicly traded.
What exchange does Nektar Therapeutics - Common Stock trade on?
Nektar Therapeutics - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Nektar Therapeutics - Common Stock?
The ticker symbol for Nektar Therapeutics - Common Stock is NKTR on the Nasdaq Stock Market
What is the current price of Nektar Therapeutics - Common Stock?
The current price of Nektar Therapeutics - Common Stock is 51.41
When was Nektar Therapeutics - Common Stock last traded?
The last trade of Nektar Therapeutics - Common Stock was at 09/17/25 10:18 AM ET
What is the market capitalization of Nektar Therapeutics - Common Stock?
The market capitalization of Nektar Therapeutics - Common Stock is 9.45B
How many shares of Nektar Therapeutics - Common Stock are outstanding?
Nektar Therapeutics - Common Stock has 9B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.